Lazard Asset Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,348
Closed -$43K 2346
2023
Q4
$43K Hold
1,348
﹤0.01% 1921
2023
Q3
$39K Buy
1,348
+729
+118% +$26.2K ﹤0.01% 1920
2023
Q2
$27K Buy
+619
New +$23.6K ﹤0.01% 2042
2020
Q1
Sell
-1,508
Closed -$23K 1728
2019
Q4
$23K Buy
+1,508
New +$17.1K ﹤0.01% 1203

Other funds holding SGRY

Lazard Asset Management's SGRY Position: Q1 2024 in Review

Lazard Asset Management sold out of Surgery Partners (SGRY) in Q1 2024, closing a stake of 1,348 shares — an estimated $43K sold.

Lazard Asset Management first reported a position in SGRY in Q4 2019 and held it in 4 quarters. The position peaked at $43K in Q4 2023. 180 funds tracked by Wall St. Rank hold SGRY as of Q1 2024.

  • Lazard Asset Management reported no remaining Surgery Partners position as of Q1 2024 after selling out during the quarter.
  • Lazard Asset Management sold 1,348 Surgery Partners shares in Q1 2024, an estimated $43K.
  • Lazard Asset Management first reported a position in Surgery Partners in Q4 2019 and held it in 4 quarters.
  • Lazard Asset Management's Surgery Partners position peaked at $43K in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2024.

Based on Lazard Asset Management's 13F filing for Q1 2024, filed 14 May 2024.